Studies of plasma .BETA.-N-acetylglucosaminidase activity in experimental and clinical diabetes mellitus.

Publisher Website
Google Scholar
Abstract
Plasma .beta.-N-acetylglucosaminidase (NAG) activity was measured in streptozotocin diabetic rats, in nondiabetic rats during starvation and refeeding, and in diabetic patients and normal subjects. The enzyme activity increased significantly in the diabetic rats and in the starved nondiabetic rats. The activity decreased markedly after insulin injection in diabetic rats and after refeeding in nondiabetic rats. The plasma NAG activity (532 .+-. 24 nmol/h per ml, mean .+-. SE) in 21 diabetics with fasting blood sugar value less than 100 mg/dl was higher than the enzyme activity (455 .+-. 15) in 42 normal subjects (P < 0.01); a more intensive treatment may be necessary to normalize the metabolic disturbance of diabetes. There was no significant difference between diabetics with and without microangiopathy. While the influence of age and abnormal liver function was noted, there was no correlation between the NAG activity and the platelet adhesiveness or between the NAG activity and the plasma triglyceride. Apparently the plasma NAG activity increases in diabetes mellitus, either with or without microangiopathy. The reason for the failure to demonstrate a significant correlation between the total plasma NAG activity and microangiopathy is discussed. The analysis of the subfractionation of the plasma NAG may be necessary to disclose a significant correlation with microangiopathy.